774 related articles for article (PubMed ID: 26784176)
1. Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization.
Maier P; Hartmann L; Wenz F; Herskind C
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26784176
[TBL] [Abstract][Full Text] [Related]
2. Individual Response to Ionizing Radiation and Personalized Radiotherapy.
Domina EA; Philchenkov A; Dubrovska A
Crit Rev Oncog; 2018; 23(1-2):69-92. PubMed ID: 29953368
[TBL] [Abstract][Full Text] [Related]
3. Targeting base excision repair as a sensitization strategy in radiotherapy.
Vens C; Begg AC
Semin Radiat Oncol; 2010 Oct; 20(4):241-9. PubMed ID: 20832016
[TBL] [Abstract][Full Text] [Related]
4. Emerging targets for radioprotection and radiosensitization in radiotherapy.
Kumar S; Singh RK; Meena R
Tumour Biol; 2016 Sep; 37(9):11589-11609. PubMed ID: 27318945
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Hsp90: a multitarget approach to radiosensitization.
Camphausen K; Tofilon PJ
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4326-30. PubMed ID: 17671112
[TBL] [Abstract][Full Text] [Related]
6. Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma.
Pal I; Dey KK; Chaurasia M; Parida S; Das S; Rajesh Y; Sharma K; Chowdhury T; Mandal M
Tumour Biol; 2016 May; 37(5):6389-402. PubMed ID: 26631035
[TBL] [Abstract][Full Text] [Related]
7. How scatter factor receptor c-MET contributes to tumor radioresistance: ready, set, scatter!
Guryanova OA; Bao S
J Natl Cancer Inst; 2011 Apr; 103(8):617-9. PubMed ID: 21464396
[No Abstract] [Full Text] [Related]
8. [Cancer stem cells, cornerstone of radioresistance and perspectives for radiosensitization: glioblastoma as an example].
Chargari C; Moncharmont C; Lévy A; Guy JB; Bertrand G; Guilbert M; Rousseau C; Védrine L; Alphonse G; Toillon RA; Rodriguez-Lafrasse C; Deutsch E; Magné N
Bull Cancer; 2012 Dec; 99(12):1153-60. PubMed ID: 23228708
[TBL] [Abstract][Full Text] [Related]
9. RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells.
King HO; Brend T; Payne HL; Wright A; Ward TA; Patel K; Egnuni T; Stead LF; Patel A; Wurdak H; Short SC
Stem Cell Reports; 2017 Jan; 8(1):125-139. PubMed ID: 28076755
[TBL] [Abstract][Full Text] [Related]
10. Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways.
Morgan MA; Lawrence TS
Clin Cancer Res; 2015 Jul; 21(13):2898-904. PubMed ID: 26133775
[TBL] [Abstract][Full Text] [Related]
11. MRE11 as a molecular signature and therapeutic target for cancer treatment with radiotherapy.
Wang YY; Hung AC; Lo S; Hsieh YC; Yuan SF
Cancer Lett; 2021 Aug; 514():1-11. PubMed ID: 34022282
[TBL] [Abstract][Full Text] [Related]
12. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
13. Isotype-Specific Inhibition of Histone Deacetylases: Identification of Optimal Targets for Radiosensitization.
Kim JH; Moon SH; No M; Kim JJ; Choi EJ; Cho BJ; Kim JS; Kim IH; Kim IA
Cancer Res Treat; 2016 Jul; 48(3):1130-40. PubMed ID: 26582395
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
[TBL] [Abstract][Full Text] [Related]
15. Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response.
Yong Y; Zhang C; Gu Z; Du J; Guo Z; Dong X; Xie J; Zhang G; Liu X; Zhao Y
ACS Nano; 2017 Jul; 11(7):7164-7176. PubMed ID: 28640996
[TBL] [Abstract][Full Text] [Related]
16. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
Gravina GL; Marampon F; Sherris D; Vittorini F; Di Cesare E; Tombolini V; Lenzi A; Jannini EA; Festuccia C
Prostate; 2014 Jun; 74(8):852-68. PubMed ID: 24715588
[TBL] [Abstract][Full Text] [Related]
17. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
18. Strategizing the clone wars: pharmacological control of cellular sensitivity to radiation.
Kimple RJ
Mol Interv; 2010 Dec; 10(6):341-53. PubMed ID: 21263160
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.
Toulany M; Rodemann HP
Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967
[TBL] [Abstract][Full Text] [Related]
20. [Biomodulation and radiotherapy].
Bourhis J; Lartigau E
Cancer Radiother; 2000 Nov; 4 Suppl 1():128s-133s. PubMed ID: 11194950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
